The Online Investor
Jaguar Health Inc (JAGX)

Jaguar Health is a commercial stage plant medicine prescription pharmaceutical company focused on developing and commercializing gastrointestinal products on a global basis. Co.'s wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used in rainforest areas. Co.'s Mytesi (crofelemer) product is approved by the U.S. Food and Drug Administration for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. In addition, a second-generation proprietary anti-secretory agent, lechlemer, is in development for cholera.
Company Name: 
Jaguar Health Inc
Website: 
www.jaguar.health
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding JAGX: 
6
Total Market Value Held by ETFs: 
$4.98M
Total Market Capitalization: 
$54.00M
% of Market Cap. Held by ETFs: 
9.22%
Quotes delayed 20 minutes

Email EnvelopeFree JAGX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
85th percentile
(ranked higher than approx. 85% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Jaguar Health Inc (JAGX) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.